Selective down-regulation of Th2 cell-mediated airway inflammation in mice by pharmacological intervention of CCR4
Selective down-regulation of Th2 cell-mediated airway inflammation in mice by pharmacological intervention of CCR4
复制标题
DOI:
10.1111/j.1365-2222.2011.03847.x
复制
发表时间:
2012-02-01
影响因子:
6.1
通讯作者:
Hiroi, T.
中科院分区:
文献类型:
--
作者:
Kaminuma, O.;Ohtomo, T.;Hiroi, T.
Background The chemokine receptor CCR4 has been implicated in Th2 cell-mediated immune responses. However, other T cell subsets are also known to participate in allergic inflammation.Objective The role of CCR4 in Th1, Th2, and Th17 cell-mediated allergic airway inflammation was investigated.Method We generated an allergic airway inflammation model by adoptive transfer of in vitro-polarized ovalbumin (OVA)-specific Th1, Th2, and Th17 cells. The effect of a low-molecular weight CCR4 antagonist, Compound 22, on this model was examined.Results Upon in vitro polarization of DO11.10 naive T cells, Th1- and Th2-polarized cells dominantly expressed CXCR3 and CCR4, respectively, while Th17-polarized cells expressed CCR6 and CCR4. Intranasal OVA-challenge of mice transferred with each T cell subset induced accumulation of T cells in the lungs. Eosinophils were also massively accumulated in Th2-transferred mice, whereas neutrophils were preferentially recruited in Th1-and Th17-transferred mice. Compound 22, as well as anti-CCL17 or anti-CCL22 antibody selectively suppressed accumulation of Th2 cells and eosinophils in the lungs of Th2-transferred and OVA-challenged mice. Compound 22 also inhibited bronchial hyper-responsiveness but had little effect on goblet cell hyperplasia in Th2-transferred and OVA-challenged mice.Conclusions and Clinical Relevance There were notable differences in allergic lung inflammation mediated by different T cell subsets. CCR4 blockage was selectively effective for suppression of Th2-mediated allergic inflammation by blocking infiltration of Th2 cells.